Development: Shining a light on hematopoietic stem cells
Blood cells perform a wide range of physiological functions in the body. Red blood cells transport oxygen from the lungs to various tissues around the body, while white blood cells protect the body against viruses, bacteria and other pathogens. However, all these different types of cells are produced by the same ‘mother cells’, the hematopoietic stem cells.
Remarkably, virtually all of the hematopoietic stem cells in adult vertebrate species arise during embryonic development (Dzierzak and Bigas, 2018). At first, these cells and their daughter cells – the hematopoietic stem and progenitor cells or HSPCs – all reside in specific developmental hematopoietic niches, before moving to different niches during adulthood.
In mammals, this niche is primarily localized in the fetal liver during development, before shifting to the bone marrow in adults. The niche in the bone marrow is sub-compartmentalized, with some hematopoietic cells residing near endothelial tissues, and others residing near bone tissues (Pinho and Frenette, 2019). However, less is known about the structure and organization of the niche in the fetal liver (Khan et al., 2016; Lewis et al., 2021). Now, in eLife, Owen Tamplin, Mark Ellisman and colleagues – including Sobhika Agarwala and Keun-Young Kim as joint first authors – report how they have combined different forms of microscopy to reveal new details of the niche during development (Agarwala et al., 2022). The experiments were performed on zebrafish, which is widely used as a model organism because it is transparent.
In the zebrafish embryo, hematopoietic stem cells migrate from the dorsal aorta to a region in the tail that is considered to be functionally equivalent to the fetal liver in mammals (Figure 1A; Murayama et al., 2006). From there, both hematopoietic stem cells and progenitor cells travel to the thymus and the kidney marrow (which is the equivalent to the bone marrow in mammals).
Agarwala et al. developed workflows that first integrated fluorescent live imaging and light sheet microscopy to generate a three-dimensional visualization of the entire kidney region of zebrafish larvae. This enabled them to monitor HSPCs lodging deep in the kidney tissues. They then performed a series of sophisticated sectioning approaches on preserved specimens that led to 3D datasets of about 3,000 tissue sections, each coupled to high-resolution imaging at the sub-cellular scale.
The experiments revealed that the developing kidney encompasses various HSPC niches, each made of different combinations of cells (Figure 1B). In the anterior kidney region, HSPCs reside as clusters adjacent to the glomerulus, the filtering unit of the kidney; in the posterior vascular and perivascular region (the space surrounding the blood vessels), they are more dispersed. Moreover, HSPCs located exclusively in the posterior perivascular region are all in direct contact with a single stromal cell (a fibroblast-like cell that can differentiate into various cell types) and three quarter of them are in contact with ganglion-like cells that produce the neurotransmitter dopamine. When dopamine signaling was experimentally blocked, the number of HSPCs within the posterior region was reduced, confirming that the nervous system has a role in regulating HSPCs (Agarwala and Tamplin, 2018).
Otherwise, and irrespective of the localization, HSPCs are in contact with endothelial cells (between two to five cells per HSPC) and some 50–60% of them are in contact with a single stromal cell. Interestingly, this has also been observed in the tail region of the embryo (Tamplin et al., 2015). Some HSPCs are also in contact with red blood cells or other HSPCs.
These results suggest that a certain minimum of cellular components is needed to maintain the stemness potential of hematopoietic stem cells, at least between developmental niches. However, to validate this idea, one needs to also discriminate in situ between short-lived stem cells that are restricted to a developmental period, long-term stem cells that persist until the adult stage, and more differentiated progenitor cells (Dzierzak and Bigas, 2018). Moreover, the contacting cells, in particular endothelial and mesenchymal stromal cells, need to be characterized further (Zhang et al., 2021; Mabuchi et al., 2021). Achieving these aims will require spatially resolved genomics and proteomics, supported by new multiplexing technologies. Insights gained from these undertakings will help move the field of regenerative medicine towards the long-term goal of being able to reconstitute bona fide hematopoietic stem cells in the laboratory.
References
-
Neural crossroads in the hematopoietic stem cell nicheTrends in Cell Biology 28:987–998.https://doi.org/10.1016/j.tcb.2018.05.003
-
Fetal liver hematopoiesis: from development to deliveryStem Cell Research & Therapy 12:139.https://doi.org/10.1186/s13287-021-02189-w
-
Cellular heterogeneity of mesenchymal stem/stromal cells in the bone marrowFrontiers in Cell and Developmental Biology 9:689366.https://doi.org/10.3389/fcell.2021.689366
-
Haematopoietic stem cell activity and interactions with the nicheNature Reviews Molecular Cell Biology 20:303–320.https://doi.org/10.1038/s41580-019-0103-9
Article and author information
Author details
Publication history
Copyright
© 2022, Schmidt
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 648
- views
-
- 110
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Developmental Biology
- Neuroscience
Mutations in Sonic Hedgehog (SHH) signaling pathway genes, for example, Suppressor of Fused (SUFU), drive granule neuron precursors (GNP) to form medulloblastomas (MBSHH). However, how different molecular lesions in the Shh pathway drive transformation is frequently unclear, and SUFU mutations in the cerebellum seem distinct. In this study, we show that fibroblast growth factor 5 (FGF5) signaling is integral for many infantile MBSHH cases and that FGF5 expression is uniquely upregulated in infantile MBSHH tumors. Similarly, mice lacking SUFU (Sufu-cKO) ectopically express Fgf5 specifically along the secondary fissure where GNPs harbor preneoplastic lesions and show that FGFR signaling is also ectopically activated in this region. Treatment with an FGFR antagonist rescues the severe GNP hyperplasia and restores cerebellar architecture. Thus, direct inhibition of FGF signaling may be a promising and novel therapeutic candidate for infantile MBSHH.
-
- Developmental Biology
- Genetics and Genomics
The establishment and growth of the arterial endothelium requires the coordinated expression of numerous genes. However, regulation of this process is not yet fully understood. Here, we combined in silico analysis with transgenic mice and zebrafish models to characterize arterial-specific enhancers associated with eight key arterial identity genes (Acvrl1/Alk1, Cxcr4, Cxcl12, Efnb2, Gja4/Cx37, Gja5/Cx40, Nrp1 and Unc5b). Next, to elucidate the regulatory pathways upstream of arterial gene transcription, we investigated the transcription factors binding each arterial enhancer compared to a similar assessment of non-arterial endothelial enhancers. These results found that binding of SOXF and ETS factors was a common occurrence at both arterial and pan-endothelial enhancers, suggesting neither are sufficient to direct arterial specificity. Conversely, FOX motifs independent of ETS motifs were over-represented at arterial enhancers. Further, MEF2 and RBPJ binding was enriched but not ubiquitous at arterial enhancers, potentially linked to specific patterns of behaviour within the arterial endothelium. Lastly, there was no shared or arterial-specific signature for WNT-associated TCF/LEF, TGFβ/BMP-associated SMAD1/5 and SMAD2/3, shear stress-associated KLF4 or venous-enriched NR2F2. This cohort of well characterized and in vivo-verified enhancers can now provide a platform for future studies into the interaction of different transcriptional and signalling pathways with arterial gene expression.